| 中文名 | 加压素V1受体(VP V1R)拮抗剂多肽 |
|---|---|
| 英文名 | (Phenylac1,D-Tyr(Et)2,Lys6,Arg8,des-Gly9)-Vasopressin |
| 英文别名 |
(Phenylac,D-Tyr(Et),Lys,g,des-Gly)-Vasopressin trifluoroacetate salt
L-gininamide, O-ethyl-N-(phenylacetyl)-D-tyrosyl-L-phenylalanyl-L-glutaminyl-L-aspaginyl-L-lysyl-L-prolyl- (9CI) (PHENYLAC1,D-TYR(ET)2,LYS6,G8,DES-GLY9)-VASOPRESSIN (Phenylac1,D-Tyr(Et)2,Lys,g,des-Gly)-Vasopressin PHENYLAC-D-TYR(ET)-PHE-GLN-ASN-LYS-PRO-ARG-NH2 PHENYLAC-D-TYR(ET)-PHE-GLN-ASN-LYS-PRO-G-NH2 (Phenylac1,D-Tyr(Et)2,Lys,g,des-Gly)-Vasopressin trifluoroacetate salt Phaa-D-Tyr(Et)-Phe-Gln-Asn-Lys-Pro-Arg-NH2 |
| 描述 | (Phenylac1,D-Tyr(Et)2,Lys6,Arg8,des-Gly9)-加压素是一种强效的血管加压素V1受体(VP-V1R)拮抗剂。(Phenylac1,D-Tyr(Et)2,Lys6,Arg8,des-Gly9)-加压素显著降低大鼠的平均动脉压(MAP)[1]。 |
|---|---|
| 相关类别 | |
| 参考文献 |
| 分子式 | C54H76N14O11 |
|---|---|
| 分子量 | 1097.27000 |
| 精确质量 | 1096.58000 |
| PSA | 421.33000 |
| LogP | 4.30690 |